Or click and collect!
Or click and collect!
Your lungs are the primary site of vapour absorption and understanding what regular inhalation does to them matters. Here is an honest, evidence-based assessment of the known effects, the open questions and how the picture compares with cigarette smoking.
Vaping affects the lungs primarily through airway inflammation and changes to mucus production from repeated vapour inhalation. It does not cause the carbon monoxide poisoning, tar accumulation or the exposure to 70-plus combustion carcinogens that make tobacco smoking one of the most harmful things a person can do to their lungs. Former smokers who switch to vaping typically see significant improvements in lung function within weeks to months. However vaping is not without lung health implications — chronic low-level airway inflammation and the long-term effects of regular vapour inhalation are still being studied, and the honest position is that we do not yet have the decades of data needed to fully characterise long-term risk.
Regular inhalation of vapour produces a measurable inflammatory response in the airways. Studies comparing vapers with non-vapers have found elevated markers of airway inflammation in vapers — including increased inflammatory cells in bronchoalveolar lavage samples and elevated cytokine levels in exhaled breath condensate. This inflammation is lower in magnitude than that observed in cigarette smokers but it is not absent. The long-term clinical significance of this chronic low-level inflammation — whether it progresses to more significant airway disease with decades of exposure — is one of the key open questions in vaping research.
Vapour inhalation stimulates goblet cells in the airway epithelium to produce more mucus as a protective response. This increased mucus production is the reason many vapers experience a cough, particularly in the early weeks of vaping or after switching brands or liquids. The cough associated with vaping is a different mechanism from smoker's cough — it is a normal defensive response to an unusual airway environment rather than evidence of structural damage. For most vapers the cough settles as the airways adjust, though it can persist in those whose airways are particularly sensitive to vapour.
The airways are lined with tiny hair-like structures called cilia that beat continuously to move mucus and trapped particles up and out of the lungs — a defence mechanism known as the mucociliary escalator. Research suggests that some components of vapour may impair ciliary function, reducing this protective clearance mechanism. Cigarette smoke is far more damaging to cilia — paralyzing them acutely with each cigarette — which is one reason why smokers accumulate far more particulate matter and mucus in the lungs than vapers. The degree of ciliary impairment from vaping is considerably lower than from smoking but is an area of ongoing investigation.
The thermal decomposition products in vapour — including small amounts of aldehydes and particulates — generate oxidative stress in airway tissue. Oxidative stress describes an imbalance between free radicals and antioxidant defences. Sustained oxidative stress in lung tissue contributes to inflammation and cellular damage. Again, the magnitude of this effect from vaping is substantially lower than from tobacco combustion but it is measurable and distinguishable from the baseline in non-vapers and non-smokers.
Understanding vaping's lung effects requires equal attention to what is absent. Tobacco smoke exposes the lungs to carbon monoxide, which binds to haemoglobin and directly reduces oxygen-carrying capacity. It deposits tar — a sticky, carcinogenic residue — on the alveolar and bronchial surfaces. It contains benzene, formaldehyde, polycyclic aromatic hydrocarbons and dozens of other confirmed carcinogens produced by combustion. It causes progressive, irreversible destruction of the alveoli (emphysema). None of these specific harms are present in vaping. The lung health comparison between vaping and smoking is not close.
"The most important thing we say when customers ask about lungs is: compared to smoking, vaping is dramatically better. Compared to not inhaling anything, it is not neutral. Both things are true and both matter."
Touch of Vape team, CoventryWithin 12 to 24 hours of stopping cigarettes, carbon monoxide levels in the blood fall significantly and oxygen-carrying capacity of the blood improves. This is one of the most rapid measurable physiological improvements from stopping smoking, and it begins immediately even before any structural lung recovery.
The ciliary paralysis caused by tobacco smoke begins to reverse within days to weeks of stopping. As cilia recover, the mucociliary escalator begins functioning more effectively, clearing accumulated mucus from the airways. Many ex-smokers who switch to vaping report a cough that worsens briefly in the first week or two — this is the airways clearing the accumulated debris that ciliary paralysis had allowed to build up, not damage from vaping.
Spirometry measurements of lung function — including FEV1 (forced expiratory volume) and FVC (forced vital capacity) — typically show measurable improvement within one to three months of switching from cigarettes to vaping. Breathlessness on exertion reduces. Exercise capacity improves. These changes are attributable to the removal of combustion-specific harms rather than any benefit from vaping itself.
Lung function continues improving as the inflammatory load from years of combustion-product exposure reduces. Respiratory infections become less frequent as immune function in the airways recovers. The rate of improvement is greatest in the first three months and slows thereafter, though recovery continues over a longer period in longer-term smokers.
Emphysema — the permanent destruction of alveolar walls from long-term smoking — does not reverse. Structural damage already done to the lungs from years of smoking is not repaired by switching to vaping or by stopping nicotine entirely. What changes is the trajectory: the rate of ongoing damage drops dramatically on switching, and functional capacity stabilises or improves even if underlying structural damage remains.
The acute lung injury deaths in the US in 2019 were caused by vitamin E acetate used as a cutting agent in illegal black-market THC vaping cartridges — not in nicotine e-liquids. This is a critical distinction that was often missing from media coverage. The EVALI outbreak does not represent a risk from regulated UK nicotine vaping products.
UK e-liquids sold under TRPR regulations must meet specific standards including banned ingredients, maximum nicotine concentrations and safety testing requirements. Buying from regulated UK retailers provides a level of product safety assurance that purchasing unregulated imports does not.
Vaping at population scale has been occurring for roughly fifteen years. The lung disease consequences of decades of vaping — comparable to the fifty-year smoking datasets that established tobacco's lung harms — do not yet exist. The current absence of a confirmed vaping-related lung disease epidemic comparable to smoking is cautiously positive, but it does not represent sufficient follow-up time to draw final conclusions about very long-term risk.
Public Health England's assessment that vaping is approximately 95% less harmful than smoking is based primarily on the absence of combustion products. The NHS supports vaping as a harm reduction tool for smokers and as a cessation pathway. Neither organisation describes vaping as without risk — both describe it as substantially less risky than smoking, which is the most accurate available assessment.
We give evidence-based answers on lung health questions every day. Come in for a straight conversation about the real risks and the real benefits of switching.
To find our Coventry store and our full range of regulated UK products, visit our Vape Shop Coventry page.
This article is part of our Health guide, covering lung health, respiratory effects and the comparison between vaping and smoking with reference to the current evidence base.
Our Health guide covers lung health, cancer risk, popcorn lung, EVALI and the broader respiratory questions our Coventry customers ask most often — all written honestly with reference to current evidence.
Find more respiratory and lung health guides in our Health guide, including detailed articles on popcorn lung, cancer risk and the effects of vaping on cardio performance.
Honest, balanced and evidence-based — because you deserve answers that reflect what the science actually shows.